News
Novel method for targeted cancer therapy

License agreement with Prometheus Laboratories Inc. in San Diego, USA

Novel method for targeted cancer therapy

Under a research and license agreement concluded between Bayer Schering Pharma and Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company based in San Diego, California, the two companies will collaborate on the development of a diagnostic platform for cancer therapy. » more
Sandra E. Peterson will be new CEO of Bayer CropScience

Bayer Group

Change of leadership
The Bayer HealthCare and Bayer CropScience subgroups and the service company Bayer Technology Services will all see changes in leadership in the coming months.
» more
High technology for solar-powered aircraft

Bayer MaterialScience

High technology for solar-powered aircraft
Bayer MaterialScience has become an official partner of the Solar Impulse project aimed at climate-friendly aviation.
» more
Researching the sustainability of new crops

Bayer CropScience

Researching the sustainability of new crops
Bayer CropScience and the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national research agency, have expanded their collaboration to include assessing the sustainability of new-generation crops.
» more
http://www.stockholders-newsletter-q1-2010.bayer.com/en/news.aspx

Copyright © Bayer AG

Print page

Search

Download Center

Publications

Special Interest